FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

434132009: Eltrombopag olamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2742683013 Eltrombopag olamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2768571019 Eltrombopag olamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
808281000172112 eltrombopag olamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eltrombopag olamine (substance) Is a Eltrombopag (substance) false Inferred relationship Some
Eltrombopag olamine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thrombopoietin receptor agonist (disposition) true Inferred relationship Some
Eltrombopag olamine (substance) Is a Thrombopoietin receptor agonist true Inferred relationship Some
Eltrombopag olamine (substance) Is a Benzoic acid and/or benzoic acid derivative (substance) true Inferred relationship Some
Eltrombopag olamine (substance) Is a Hydrazine and/or hydrazine derivative true Inferred relationship Some
Eltrombopag olamine (substance) Is a Pyrazole and/or pyrazole derivative (substance) true Inferred relationship Some
Eltrombopag olamine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Eltrombopag (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eltrombopag olamine (substance) Inferred relationship Some 1
Eltrombopag (as eltrombopag olamine) 12.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eltrombopag olamine (substance) Inferred relationship Some 1
Eltrombopag (as eltrombopag olamine) 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eltrombopag olamine (substance) Inferred relationship Some 1
Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Eltrombopag olamine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start